About Enzene Biosciences
Enzene Biosciences is a company based in Pune (India) founded in 2006.. Enzene Biosciences has raised $50 million across 1 funding round from investors including Eight Roads Ventures and F-Prime Capital. The company has 665 employees as of September 25, 2025. Enzene Biosciences offers products and services including EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services. Enzene Biosciences operates in a competitive market with competitors including Hybio Pharmaceutical, AmbioPharm, Ocelot Bio, Rameda and Shaanxi Micot Technology, among others.
- Headquarter Pune, India
- Employees 665 as on 25 Sep, 2025
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enzene Biosciences Limited
- Date of Incorporation 28 Aug, 2006
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$33.33 M (USD)88.93as on Mar 31, 2024
-
Net Profit
$-1.54 M (USD)24.22as on Mar 31, 2024
-
EBITDA
$-1.21 M (USD)70.24as on Mar 31, 2024
-
Total Equity Funding
$50 M (USD)
in 1 rounds
-
Latest Funding Round
$50 M (USD), Series C
Jan 30, 2023
-
Investors
Eight Roads Ventures
& 1 more
-
Employee Count
665
as on Sep 25, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enzene Biosciences
Enzene Biosciences offers a comprehensive portfolio of products and services, including EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Continuous bioprocess for efficient biologics production and cost reduction
Solutions for target identification and antibody engineering processes
Support for cell line engineering and formulation development
Tech transfer and scale-up for biologics manufacturing
Unlock access to complete
Unlock access to complete
Funding Insights of Enzene Biosciences
Enzene Biosciences has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Series C round of $50 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $50.0M
-
First Round
First Round
(30 Jan 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series C - Enzene Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enzene Biosciences
Enzene Biosciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enzene Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enzene Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enzene Biosciences Comparisons
Competitors of Enzene Biosciences
Enzene Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hybio Pharmaceutical, AmbioPharm, Ocelot Bio, Rameda and Shaanxi Micot Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
|
| domain | founded_year | HQ Location |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| domain | founded_year | HQ Location |
Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products
|
|
| domain | founded_year | HQ Location |
Drug R&D services for cardiovascular and metabolic diseases are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enzene Biosciences
Frequently Asked Questions about Enzene Biosciences
When was Enzene Biosciences founded?
Enzene Biosciences was founded in 2006 and raised its 1st funding round 17 years after it was founded.
Where is Enzene Biosciences located?
Enzene Biosciences is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Is Enzene Biosciences a funded company?
Enzene Biosciences is a funded company, having raised a total of $50M across 1 funding round to date. The company's 1st funding round was a Series C of $50M, raised on Jan 30, 2023.
How many employees does Enzene Biosciences have?
As of Sep 25, 2025, the latest employee count at Enzene Biosciences is 665.
What is the annual revenue of Enzene Biosciences?
Annual revenue of Enzene Biosciences is $33.33M as on Mar 31, 2024.
What does Enzene Biosciences do?
Enzene Biosciences was founded in 2006 in Pune, India, as a subsidiary of Alkem Laboratories Limited. Operations are centered on biosimilars in the biotechnology sector, with platforms established in molecular biology, protein expression, and fermentation for microbial, insect, and mammalian cells. Expertise includes upstream and downstream process development, bio-analytics for peptides and proteins, cell-based bioassays, and peptide synthesis via solution and solid-state methods.
Who are the top competitors of Enzene Biosciences?
Enzene Biosciences's top competitors include Hybio Pharmaceutical, PolyPeptide and AmbioPharm.
What products or services does Enzene Biosciences offer?
Enzene Biosciences offers EnzeneX Platform, Drug Discovery Services, Drug Development Services, and Drug Manufacturing Services.
Who are Enzene Biosciences's investors?
Enzene Biosciences has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.